The reaction between cisplatin and DNA is conveniently studied using fluorescently labeled oligonucleotides and gel electrophoresis; as an example of application, the inhibition of this reaction by citrate is demonstrated, which might 10
react with various nucleophilic species including DNA. 7, 8 Mechanisms related to electron transfer have also been proposed. 9 Due to the lack of appropriate analytical tools to follow cisplatin inside live cells, 5 most studies were carried out in simple buffers. The cellular environment, however, is 25 much more complex containing numerous small molecules, nucleic acids and proteins that compete for cisplatin binding. 10, 11 The cisplatin concentration inside cells is estimated to be just nanomolar to low micromolar. 5 Many cellular compounds can tightly bind to cisplatin, leaving little 30 free cisplatin for DNA binding. Examples of such competitors include sulfer containing proteins, 12, 13 glutathione (GSH), 14, 15 and even inorganic anions. 16 Before cisplatin can react with DNA, it has to be released from these competing ligands. 17 Many inorganic ions have a high cellular concentration and 35 may affect cisplatin binding to DNA. For example, phosphate, acetate, and carbonate have been shown to bind to cisplatin. 16, [18] [19] [20] [21] Citrate is an important cellular metabolite but its effect on cisplatin has not been studied. Cellular citrate concentration is high in Aspergillus niger (~2-30 mM), 22 and 40 in Saccharomyces cerevisiae (~3 mM). 23, 24 In human tissues, citrate was reported to be 0.2-0.45 mM. 25 This is likely to be under-estimated since most citrate resides in mitochondria, where it is formed and utilized to make lipids. 26 It has also been suggested that the real target of cisplatin might be the 45 mitochondria DNA instead of the nuclear DNA, 27 where the role of citrate is even more relevant. Therefore, we are interested in studying the effect of citrate on the reaction between cisplatin and DNA. Cisplatin binding to DNA has been monitored using 50 HPLC, 28, 29 NMR, 30 electrochemistry, 31 mass spectrometry, 32 and elemental analysis. 33 Compared to these methods, gel electrophoresis is more cost-effective and readily accessible to many researchers. It can tolerate complex sample matrix without worrying about clotting of column or spectroscopic 55 interference. Gel electrophoresis has been used to confirm DNA binding by cisplatin in a few reports, 16, 28, 34 where most employed radioisotope labels or DNA staining dyes for imaging long biolgical DNA. Given the development and recent applications of covalent fluorophore labels, such 60 advances have not been widely applied to study DNA/cisplatin reaction. 35 Herein, we use gel electrophoresis to follow this reaction in citrate buffer. FAM (carboxyfluorescein)-labeled DNAs are popular probes because of their low cost and high quantum yield. As an initial test, we employed FAM-labeled 15-mer DNA homopolymers. The DNAs were mixed with increasing concentrations of cisplain for 16 h and the samples were then loaded into a non-denaturing polyacrylamide gel. A gradual shift of the FAM-A15 band with reduced mobility was 70 observed with increasing cisplatin concentration ( Figure 1A ), suggesting reaction between this DNA and cisplatin. The Pt-DNA adduct did not migrate as a single band, suggesting the presence of a broad range of products, possibly due to different levels and positions of platination. Fluorescence 75 quenching was also observed, especially at high Pt concentrations. On the other hand, no shift was observed with FAM-T15 and its fluorescence just dropped in intensity with increasing cisplatin concentration ( Figure 1B ). Reactions also occurred with FAM-C15 and its product distribution pattern 80 was quite different, where discrete bands were observed at low Pt concentrations and the gel smeared at high Pt concentrations ( Figure 1C ). Finally, FAM-G15 showed slightly smeared gel even for the initial free DNA, possibly due to its tendency to form various secondary structures such as inter- 85 and intra-molecular quadruplexes ( Figure 1D ). Mass spectrum of FAM-G15 showed a few high molecular weight species, consistent with the smeared gel (Figure S1, ESI). Addition of cisplatin produced a clear shift, consistent with the fact that cisplatin has high affinity toward guanine.
This initial test suggests that FAM-labeled DNA and gel electrophoresis can be used to study DNA reaction with cisplatin but fluorescence quenching needs to be suppressed. We next tested Alexa Fluor 647 (AF) labeled T15, since AF is 5 known to be a more stable fluorophore. We chose T15 for its low reactivity with cisplatin and fluorescence intensity can be directly compared. Using a short incubation time of 2 h, ~20% qenching was observed with FAM, while AF was not significantly quenched (Figure 2A) . It needs to be noted that 10 longer incubation can also quench AF, but to a less extent than FAM quenching. Therefore, we chose to use AF-labeled DNA for subsequent studies. First, the cisplatin concentration-dependent study was 20 repeated, where AF-A15 still showed a similar mobility shift but the overall fluorescence intensity was stronger ( Figure  2B ). On the other hand, no reaction took place with AF-T15 as expected and the band intensity was quite consistent ( Figure  2C ). Next a time-dependent study was performed with AF- 25 A15. It is clear that the bands shifted to lower mobility over time ( Figure 2D ). We quantified the relative mobility shift by measuring the center of each band and obtained a reaction rate of 0.36 h -1 between cisplatin and AF-A15 ( Figure S2 ). This rate is comparable with the literature reports. 16 30 After optimizing the assay conditions, we next studied the reaction in citrate buffers using AF-A15. First, 0.25 mM cisplatin was mixed with various concentrations of citrate for 24 h to allow complex formation. Then AF-A15 was added and incubated for another 16 h. In Figure 2E , the first lane on the 35 left is the free DNA without cisplatin. All the other lanes contained cisplatin and the citrate concentration was gradually decreased. We observed a gradual mobility shift, which can be pictured as an inhibition curve and the middle point is ~0.5 mM citrate. Since the Pt concentration was 0.25 mM, the 40 inhibition effect by citrate is close to quantitative. Strong free DNA bands were observed with 5 mM citrate, where no cisplatin/DNA adduct was detected. Since cisplatin binding to DNA is thermodynamically stronger than to most other ligands, 17 inhibit was incomplete at low citrate concentrations. 45 After reacting with citrate, negatively charged complexes are formed, which might be a kinetic reason to disfavor the reaction with negatively charged DNA. Different organelles inside a cell have different pH values. 60 For example, endosomes and lysosomes are acidic and cancer tissues usually also have lower pH. 36 The pH-dependent study is convenient to carry out with citrate since it can be used as a buffer over a wide pH range. Moderate DNA binding to cisplatin was observed only at pH 3 ( Figure 3A ), while 65 binding was completely inhibited at higher pH. This might be related to the protonation of citrate at pH 3, thus suppressing its binding to cisplatin (the pKa values of citrate are 3.14, 4.75 and 6.39). Overall, citrate is a strong inhibitor of cisplatin binding to poly-A DNA over a wide pH range. 70 In addition to cisplatin, a few other Pt-based drugs have also been approved for clinical use such as oxaliplatin and carboplatin. Next we studied their reaction with DNA in citrate ( Figure 3B ). Interestingly, we only observed reaction with cisplatin while no binding was detected with other Pt 75 complexes in 16 h. A moderate reaction with carboplatin was observed only after 48 h ( Figure S3 ). The main difference between cisplatin and carboplatin or oxaliplatin is that the two chloride ligands are replaced by two chelating carboxyl groups. The chloride leaving groups in cisplatin are liable 80 compared to carboxyl leaving groups, which are moderately stable ( Figure 3C ). Therefore, cisplatin can be hydrolyzed and then react with citrate, while carboplatin or oxaliplatin does not react with citrate as readily. Mass spectrometry shows the presence of both mono-coordinated and chelated products 85 between citrate and cisplatin ( Figure S4) .
The above studies mainly used A15 DNA since it forms discrete bands in gel while the G15 products smeared more. It needs to be noted that the inhibition effect is less significant for G15 ( Figure S5 ). An important advantage of fluorescence is multiplexed detection. With two different fluorophores, we 5 next tested the effect of citrate in reaction selectivity between adenine and guanine. In the absence of citrate, both FAM-G15 and AF-A15 reacted and the mobility decreased with time ( Figure 3D, E, F) . In the presence of citrate, AF-A15 was completely inhibited as expected ( Figure 3G) , while FAM-G15 10 still reacted ( Figure 3H ), although slower than that in the absence of citrate. The merged band changed from orange to red after 4 h ( Figure 3I ), suggesting platination of FAM-G15. Therefore, an interesting effect of citrate is to increase the selectivity of cisplatin towards guanine compared to adenine, 15 which might have implications for guanine being the eventual target of cisplatin. [37] [38] [39] In summary, we employed fluorescently-labeled oligonucleotides for studying the reaction between cisplatin and DNA. Important reaction information such as product 30 distribution, kinetics, and stoichiometry can all be obtained with this simple method. We further showed that citrate is an inhibitor for this reaction but can increase selectivity toward guanine over adenine.
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